Natural aminoacyl tRNA synthetase fragment enhances cardiac function after myocardial infarction

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  McCormick, Margaret E ^a   Rojas, Mauricio ^a   Moser Katz, Tyler ^a   Tzima, Ellie ^a   Reader, John S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC AGENT; CASPASE 3; CYCLINE; MINI AMINO ACID TRANSFER RNA LIGASE; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG; VIMENTIN; AMINO ACID TRANSFER RNA LIGASE; BIOLOGICAL PRODUCT; PEPTIDE FRAGMENT;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FIBROBLAST; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CAPILLARY; HEART PROTECTION; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; SCAR FORMATION; TISSUE REPAIR; TREATMENT OUTCOME; ANIMAL; C57BL MOUSE; CAPILLARY; CHEMISTRY; DRUG EFFECTS; FIBROSIS; HEART; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY;

AMINO ACYL-TRNA SYNTHETASES; ANIMALS; APOPTOSIS; BIOLOGICAL PRODUCTS; CAPILLARIES; CELL PROLIFERATION; FIBROBLASTS; FIBROSIS; HEART; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 84907829479     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109325     Document Type: Article

References (44)

1. Guo M, Schimmel P (2013) Essential nontranslational functions of tRNA synthetases. Nat Chem Biol 9:145-153.
2. Yao P, Fox PL (2013) Aminoacyl-tRNA synthetases in medicine and disease. EMBO Mol Med 5:332-343.
3. Wakasugi K, Schimmel P (1999) Two distinct cytokines released from a human aminoacyl-tRNA synthetase. Science 284:147-151.
4. Greenberg Y, King M, Kiosses WB, Ewalt K, Yang X, et al. (2008) The novel fragment of tyrosyl tRNA synthetase, mini-TyrRS, is secreted to induce an angiogenic response in endothelial cells. Faseb J 22:1597-1605.
5. Wakasugi K, Slike BM, Hood J, Ewalt KL, Cheresh DA, et al. (2002) Induction of angiogenesis by a fragment of human tyrosyl-tRNA synthetase. J Biol Chem 277:20124-20126.
6. Jessup M, Brozena S (2003) Heart failure. N Engl J Med 348:2007-2018.
7. Depre C, Vatner SF (2005) Mechanisms of cell survival in myocardial hibernation. Trends Cardiovasc Med 15:101-110.
8. Saxena A, Fish JE, White MD, Yu S, Smyth JW, et al. (2008) Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction. Circulation 117:2224-2231.
9. Banquet S, Gomez E, Nicol L, Edwards-Levy F, Henry JP, et al. (2011) Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failure. Circulation 124:1059-1069.
10. Henry TD, Annex BH, McKendall GR, Azrin MA, Lopez JJ, et al. (2003) The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis. Circulation 107:1359-1365.
11. Simons M, Annex BH, Laham RJ, Kleiman N, Henry T, et al. (2002) Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation 105:788-793.
12. House SL, Branch K, Newman G, Doetschman T, Schultz Jel J (2005) Cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2 is mediated by the MAPK cascade. Am J Physiol Heart Circ Physiol 289:H2167-2175.
13. Meloni M, Caporali A, Graiani G, Lagrasta C, Katare R, et al. (2010) Nerve growth factor promotes cardiac repair following myocardial infarction. Circ Res 106:1275-1284.
14. Zhang G, Nakamura Y, Wang X, Hu Q, Suggs LJ, et al. (2007) Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit+ cell homing to the infarcted heart. Tissue Eng 13:2063-2071.
15. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, et al. (2003) Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9:1195-1201.
16. Smart N, Dube KN, Riley PR (2013) Epicardial progenitor cells in cardiac regeneration and neovascularisation. Vascul Pharmacol 58:164-173.
17. Amado LC, Saliaris AP, Schuleri KH, St John M, Xie JS, et al. (2005) Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A 102:11474-11479.
18. Johnston PV, Sasano T, Mills K, Evers R, Lee ST, et al. (2009) Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation 120:1075-1083, 1077 p following 1083.
19. Li Z, Wu JC, Sheikh AY, Kraft D, Cao F, et al. (2007) Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease. Circulation 116:I46-54.
20. Yamanaka S (2012) Induced pluripotent stem cells: past, present, and future. Cell Stem Cell 10:678-684.
21. Gu M, Nguyen PK, Lee AS, Xu D, Hu S, et al. (2012) Microfluidic single-cell analysis shows that porcine induced pluripotent stem cell-derived endothelial cells improve myocardial function by paracrine activation. Circ Res 111:882-893.
22. Bock-Marquette I, Saxena A, White MD, Dimaio JM, Srivastava D (2004) Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 432:466-472.
23. Brutsaert DL (2003) Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiol Rev 83:59-115.
24. Willis MS, Rojas M, Li L, Selzman CH, Tang RH, et al. (2009) Muscle ring finger 1 mediates cardiac atrophy in vivo. Am J Physiol Heart Circ Physiol 296:H997-H1006.
25. Duan J, Gherghe C, Liu D, Hamlett E, Srikantha L, et al. (2012) Wnt1/betacatenin injury response activates the epicardium and cardiac fibroblasts to promote cardiac repair. Embo J 31:429-442.
26. Yang XL, Kapoor M, Otero FJ, Slike BM, Tsuruta H, et al. (2007) Gain-of-function mutational activation of human tRNA synthetase procytokine. Chem Biol 14:1323-1333.
27. Willis MS, Ike C, Li L, Wang DZ, Glass DJ, et al. (2007) Muscle ring finger 1, but not muscle ring finger 2, regulates cardiac hypertrophy in vivo. Circ Res 100:456-459.
28. Souders CA, Bowers SL, Baudino TA (2009) Cardiac fibroblast: the renaissance cell. Circ Res 105:1164-1176.
29. Shinde AV, Frangogiannis NG (2013) Fibroblasts in myocardial infarction: A role in inflammation and repair. J Mol Cell Cardiol.
30. Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, et al. (2001) Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 344:1750-1757.
31. Loughran JH, Elmore JB, Waqar M, Chugh AR, Bolli R (2012) Cardiac stem cells in patients with ischemic cardiomyopathy: discovery, translation, and clinical investigation. Curr Atheroscler Rep 14:491-503.
32. Bearzi C, Rota M, Hosoda T, Tillmanns J, Nascimbene A, et al. (2007) Human cardiac stem cells. Proc Natl Acad Sci U S A 104:14068-14073.
33. Wakasugi K, Schimmel P (1999) Highly differentiated motifs responsible for two cytokine activities of a split human tRNA synthetase. J Biol Chem 274:23155-23159.
34. Cheng G, Zhang H, Yang X, Tzima E, Ewalt KL, et al. (2008) Effect of Mini-tyrosyl-tRNA Synthetase on Ischemic Angiogenesis, Leukocyte Recruitment and Vascular Permeability. Am J Physiol Regul Integr Comp Physiol.
35. Zeng R, Chen YC, Zeng Z, Liu WQ, Jiang XF, et al. (2011) Effect of mini-tyrosyl-tRNA synthetase/mini-tryptophanyl-tRNA synthetase on ischemic angiogenesis in rats: proliferation and migration of endothelial cells. Heart Vessels 26:69-80.
36. Jones SP, Greer JJ, Van Haperen R, Duncker DJ, De Crom R, et al. (2003) Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice. Proc Natl Acad Sci U S A 100:4891-4896.
37. Bolli R (2006) Abstract 1267: intracoronary administration of cardiac stem cells improves cardiac function in pigs with old infarction. Circulation 114:239.
38. Rota M, Padin-Iruegas ME, Misao Y, De Angelis A, Maestroni S, et al. (2008) Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res 103:107-116.
39. Dawn B, Stein AB, Urbanek K, Rota M, Whang B, et al. (2005) Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci U S A 102:3766-3771.
40. Camelliti P, Borg TK, Kohl P (2005) Structural and functional characterisation of cardiac fibroblasts. Cardiovasc Res 65:40-51.
41. Takeda N, Manabe I, Uchino Y, Eguchi K, Matsumoto S, et al. (2010) Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload. J Clin Invest 120:254-265.
42. Baudino TA, Carver W, Giles W, Borg TK (2006) Cardiac fibroblasts: friend or foe? Am J Physiol Heart Circ Physiol 291:H1015-1026.
43. Oka T, Xu J, Kaiser RA, Melendez J, Hambleton M, et al. (2007) Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ Res 101:313-321.
44. Accornero F, Van Berlo JH, Benard MJ, Lorenz JN, Carmeliet P, et al. (2011) Placental growth factor regulates cardiac adaptation and hypertrophy through a paracrine mechanism. Circ Res 109:272-280.